Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ICVB-1042 |
Synonyms | |
Therapy Description |
ICVB-1042 is an oncolytic adenovirus that selectively infects tumor cells, which may result in lysis of tumor cells and inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 681). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ICVB-1042 | ICVB 1042|ICVB1042 | ICVB-1042 is an oncolytic adenovirus that selectively infects tumor cells, which may result in lysis of tumor cells and inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 681). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05904236 | Phase I | ICVB-1042 | Safety and Tolerability of Intravenous Administration of ICVB-1042 | Recruiting | USA | 0 |